Maggie Q’s ActivatedYou is betting on creatine, but one ingredient will carry most of the scientific weight
ActivatedYou launches Vital Strength with 5 g creatine, BCAAs and vitamin D3, testing whether evidence-led dosing can win wellness consumers.
Pharma & Biotech
Pharma & Biotech
A promising eye cancer drug shrank tumors in phase 1, so why did Novartis stop developing DYP688?
DYP688 showed early activity and manageable toxicity in metastatic uveal melanoma, but Novartis has halted development despite the clinical signal.
Pharma & Biotech
Why Asymchem’s first FDA inspection at Dunhua 2 matters far beyond one carbapenem API
Asymchem’s Dunhua 2 site completes its first FDA inspection, advancing continuous carbapenem API manufacturing and U.S. supply readiness.
Pharma & Biotech
NewAmsterdam Pharma and Menarini receive positive CHMP opinion for Ubeslo and Evlarco
CHMP backs Ubeslo and Evlarco, moving obicetrapib closer to European authorization while PREVAIL tests cardiovascular outcomes.
Pharma & Biotech
Estrella’s EB103 kept early lymphoma remissions intact, but one trial detail still needs explaining
Estrella advances EB103 into STARLIGHT-1 expansion as early lymphoma remissions endure, while trial scale, safety and funding remain key tests.
Pharma & Biotech
Organon VTAMA analysis shows consistent atopic dermatitis efficacy across children and adults
Organon’s VTAMA Phase 3 analysis shows consistent atopic dermatitis responses across children and adults, strengthening its clinical case.
Pharma & Biotech
Why Enhertu’s EU recommendation could end a decade of stability in first-line HER2 breast cancer treatment
EU regulators back Enhertu plus pertuzumab for first-line HER2-positive metastatic breast cancer, shifting focus to approval, safety and access.
Pharma & Biotech
Kenvue wins FDA approval for first OTC acetaminophen and naproxen sodium combination
FDA approval gives Kenvue a 12-hour Tylenol and naproxen product, but safety warnings and retail execution will shape its commercial impact.
Pharma & Biotech
Why American Regent’s single-lot papaverine recall carries a potentially serious injectable safety risk
American Regent recalls one papaverine injection lot after glass or paraformaldehyde particles were found, raising serious injectable safety concerns.
Pharma & Biotech
Care Career’s MAS Medical Staffing deal reveals a much bigger $250m ambition
Care Career acquires MAS Medical Staffing, lifts annual revenue above $150 million and targets a $250 million healthcare workforce platform.